-
1
-
-
0345224581
-
Chapter 46: Immunocompromised host infections
-
Kode-Kimble MA, Young LY, eds. Applied Therapeutics Applied Therapeutics Inc
-
Mandler HD, Dudley MN. Chapter 46: Immunocompromised host infections. In: Kode-Kimble MA, Young LY, eds. Applied Therapeutics. The clinical use of drugs. Fifth Ed. Applied Therapeutics Inc; 1992.
-
(1992)
The Clinical use of Drugs. Fifth Ed.
-
-
Mandler, H.D.1
Dudley, M.N.2
-
2
-
-
0344361822
-
Chapter 14: Aminoglycosides
-
Evans WE, Schentag EE and Jusko J, eds. Applied Pharmacokinetics. Vancouver: Applied Therapeutics, Inc
-
Zaske DE. Chapter 14: Aminoglycosides. In: Evans WE, Schentag EE and Jusko J, eds. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring. Vancouver: Applied Therapeutics, Inc; 1992.
-
(1992)
Principles of Therapeutic Drug Monitoring
-
-
Zaske, D.E.1
-
3
-
-
0016394711
-
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis
-
Noone P, Parsons TMC, Pattison JR, Slack RBC, Garfield-Davies D, Huges K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. BMJ 1974;1:477-81.
-
(1974)
BMJ
, vol.1
, pp. 477-481
-
-
Noone, P.1
Parsons, T.M.C.2
Pattison, J.R.3
Slack, R.B.C.4
Garfield-Davies, D.5
Huges, K.6
-
4
-
-
0023119430
-
Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration
-
Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-9.
-
(1987)
J Infect Dis
, vol.155
, pp. 93-99
-
-
Moore, R.D.1
Lietman, P.S.2
Smith, C.R.3
-
6
-
-
0016709021
-
Predictability of blood levels of gentamicin in man
-
Barza M, Brown RB, Shen D, Gibaldi M, Weinstein L. Predictability of blood levels of gentamicin in man. J Infect Dis 1975;132:165-74.
-
(1975)
J Infect Dis
, vol.132
, pp. 165-174
-
-
Barza, M.1
Brown, R.B.2
Shen, D.3
Gibaldi, M.4
Weinstein, L.5
-
7
-
-
0018979475
-
Gentamicin dosage requirements: Wide interpatient variation in 242 surgery patients with normal renal function
-
Zaske DE, Cipolle RJ, Strate RJ. Gentamicin dosage requirements: wide interpatient variation in 242 surgery patients with normal renal function. Surgery 1980;87:164-9.
-
(1980)
Surgery
, vol.87
, pp. 164-169
-
-
Zaske, D.E.1
Cipolle, R.J.2
Strate, R.J.3
-
8
-
-
0028341368
-
Selection of optimal prophylactic amonoglycoside dosage in cancer patients: Population pharmacokinetic approaches
-
Ordovas JP, Ronchera CL, Poveda N, Jimenez NV, Lopez R. Selection of optimal prophylactic amonoglycoside dosage in cancer patients: population pharmacokinetic approaches. J Clin Pharm Ther 1994;19:47-56.
-
(1994)
J Clin Pharm Ther
, vol.19
, pp. 47-56
-
-
Ordovas, J.P.1
Ronchera, C.L.2
Poveda, N.3
Jimenez, N.V.4
Lopez, R.5
-
9
-
-
0027217273
-
Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy
-
Inciardi JF, Batra KK. Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy. Antimicrob Agts Chemother 1993;37:1025-7.
-
(1993)
Antimicrob Agts Chemother
, vol.37
, pp. 1025-1027
-
-
Inciardi, J.F.1
Batra, K.K.2
-
12
-
-
0017204845
-
Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients
-
Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm 1976;4:183-95.
-
(1976)
J Pharmacokinet Biopharm
, vol.4
, pp. 183-195
-
-
Sawchuk, R.J.1
Zaske, D.E.2
-
13
-
-
0031976778
-
Population pharmacokinetic parameters of gentamicin in solid tumour patients. Estimation by one and two stage methods
-
Ortega A, Aldaz A, Giráldez J, Brugarolas A. Population pharmacokinetic parameters of gentamicin in solid tumour patients. Estimation by one and two stage methods. Ther Drug Monit 1998;20:184-90.
-
(1998)
Ther Drug Monit
, vol.20
, pp. 184-190
-
-
Ortega, A.1
Aldaz, A.2
Giráldez, J.3
Brugarolas, A.4
-
14
-
-
0019365237
-
Reporting results of cancer treatment
-
FRCP(C)
-
Miller AB, FRCP(C), Hougstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
Miller, A.B.1
Hougstraten, B.2
Staquet, M.3
Winkler, A.4
-
16
-
-
0028281786
-
Lean Body Mass as a predictor of drug dosage. Implications for drug therapy
-
Morgan DJ, Bray KM. Lean Body Mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 1994;26:92-307.
-
(1994)
Clin Pharmacokinet
, vol.26
, pp. 92-307
-
-
Morgan, D.J.1
Bray, K.M.2
-
17
-
-
0022608733
-
Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin
-
Burton ME, Chow MSS, Platt DR, Day RB, Brater DC, Vasko MR. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. Clin Pharm 1986;5:143-9.
-
(1986)
Clin Pharm
, vol.5
, pp. 143-149
-
-
Burton, M.E.1
Chow, M.S.S.2
Platt, D.R.3
Day, R.B.4
Brater, D.C.5
Vasko, M.R.6
-
18
-
-
0023852057
-
Validation of the use of bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing
-
Chrystyn H. Validation of the use of bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing. Drug Intell Clin Pharm 1988;22:49-53.
-
(1988)
Drug Intell Clin Pharm
, vol.22
, pp. 49-53
-
-
Chrystyn, H.1
-
19
-
-
0023155096
-
Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis
-
Mann MJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm 1987;6:148-53.
-
(1987)
Clin Pharm
, vol.6
, pp. 148-153
-
-
Mann, M.J.1
Fuhs, D.W.2
Awang, R.3
Ndemo, F.A.4
Cerra, F.B.5
-
20
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Crockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-4.
-
(1976)
Nephron
, vol.16
, pp. 31-34
-
-
Crockcroft, D.W.1
Gault, M.H.2
-
21
-
-
0002953816
-
A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex and weight
-
Jelliffe RW, Jelliffe SM. A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex and weight. Math Biosci 1972;14:17-24.
-
(1972)
Math Biosci
, vol.14
, pp. 17-24
-
-
Jelliffe, R.W.1
Jelliffe, S.M.2
-
22
-
-
0003457049
-
-
New Haven and London. Yale University Press
-
Feinstein AR. Multivariable Analysis. New Haven and London. Yale University Press, 1996.
-
(1996)
Multivariable Analysis
-
-
Feinstein, A.R.1
-
23
-
-
0027455452
-
Aminoglycoside volume of distribution in postoperative patients with septic shock
-
Oparaoji EC, Cornwell EE, Hekmat E, Cheong RL, Addir JJS, Siram S. Aminoglycoside volume of distribution in postoperative patients with septic shock. Clin Pharm 1993;12:131-4.
-
(1993)
Clin Pharm
, vol.12
, pp. 131-134
-
-
Oparaoji, E.C.1
Cornwell, E.E.2
Hekmat, E.3
Cheong, R.L.4
Addir, J.J.S.5
Siram, S.6
-
24
-
-
0025978835
-
Is there a reliable index of glomerular filtration rate in critically ill patients?
-
Robert S, Zarowitz BJ. Is there a reliable index of glomerular filtration rate in critically ill patients? DICP Ann Pharmacother 1991;25:169-78.
-
(1991)
DICP Ann Pharmacother
, vol.25
, pp. 169-178
-
-
Robert, S.1
Zarowitz, B.J.2
-
25
-
-
0019487328
-
Influence of range of renal function and liver disease on predictability of creatinine clearance
-
Hull JH, Hark LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM. Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981;29(4):516-21.
-
(1981)
Clin Pharmacol Ther
, vol.29
, Issue.4
, pp. 516-521
-
-
Hull, J.H.1
Hark, L.J.2
Koch, G.G.3
Wargin, W.A.4
Chi, S.L.5
Mattocks, A.M.6
-
26
-
-
0000793889
-
Estimation of creatinine clearance from serum creatinine concentration-a review
-
Lott RS, Hayton WL. Estimation of creatinine clearance from serum creatinine concentration-a review. Drug Intell Clin Pharm 1978;12:140-50.
-
(1978)
Drug Intell Clin Pharm
, vol.12
, pp. 140-150
-
-
Lott, R.S.1
Hayton, W.L.2
-
27
-
-
0344361820
-
Estimation of creatinine clearance in malnourished patients
-
Lau AH, Bek SI, Posser T, Stonich T. Estimation of creatinine clearance in malnourished patients. Clin Pharm 1991;10:706-10.
-
(1991)
Clin Pharm
, vol.10
, pp. 706-710
-
-
Lau, A.H.1
Bek, S.I.2
Posser, T.3
Stonich, T.4
-
28
-
-
0020533651
-
Decreased rate of creatinine production in patients with hepatic disease: Implications for estimation of creatinine clearance
-
Cochetto DM, Tschanz Ch, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: Implications for estimation of creatinine clearance. Ther Drug Monit 1983;5:161-68.
-
(1983)
Ther Drug Monit
, vol.5
, pp. 161-168
-
-
Cochetto, D.M.1
Tschanz, Ch.2
Bjornsson, T.D.3
-
29
-
-
0023771720
-
Superiority of disease-specific over conventional formula in predicing creatinine clearance from serum creatinine in patients with liver cirrhosis
-
Echizen H, Ishizaki T. Superiority of disease-specific over conventional formula in predicing creatinine clearance from serum creatinine in patients with liver cirrhosis. Ther Drug Monit 1988;10:369-75.
-
(1988)
Ther Drug Monit
, vol.10
, pp. 369-375
-
-
Echizen, H.1
Ishizaki, T.2
-
30
-
-
0018472223
-
Use of serum creatinine concentrations to determine renal function
-
Bjornsson TD. Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 1979;4:200-22.
-
(1979)
Clin Pharmacokinet
, vol.4
, pp. 200-222
-
-
Bjornsson, T.D.1
-
31
-
-
0026713374
-
Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients
-
Zarowitz BJ, Robert S, Peterson EL. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother 1992;26:1205-10.
-
(1992)
Ann Pharmacother
, vol.26
, pp. 1205-1210
-
-
Zarowitz, B.J.1
Robert, S.2
Peterson, E.L.3
-
32
-
-
0027422833
-
Predicting vancomycin pharmacokinetics by using aminoglycosides pharmacokinetics
-
Welch LP, Leader WG, Chandler MHH. Predicting vancomycin pharmacokinetics by using aminoglycosides pharmacokinetics. Clin Pharm 1993;12:909-13.
-
(1993)
Clin Pharm
, vol.12
, pp. 909-913
-
-
Welch, L.P.1
Leader, W.G.2
Chandler, M.H.H.3
-
33
-
-
0027291455
-
Estimation of creatinine clearance in patients with gynecologic cancer
-
Tsubaki T, Goodin S, Leader WG, Chandler MHH. Estimation of creatinine clearance in patients with gynecologic cancer. Clin Pharm 1993;12:685-90.
-
(1993)
Clin Pharm
, vol.12
, pp. 685-690
-
-
Tsubaki, T.1
Goodin, S.2
Leader, W.G.3
Chandler, M.H.H.4
-
34
-
-
0344361818
-
-
Laboratory of Applied Pharmacokinetics. University of Southern California. School of Medicine. Los Angeles. California
-
Jelliffe RW, Schumitzky A, Van Guilder M. USC*PACK collection of PC programs. Laboratory of Applied Pharmacokinetics. University of Southern California. School of Medicine. Los Angeles. California.
-
USC*PACK Collection of PC Programs
-
-
Jelliffe, R.W.1
Schumitzky, A.2
Van Guilder, M.3
-
35
-
-
0344361817
-
Farmacocinética aplicada: Aminoglicósidos
-
Miranda, Maldonado. Farmacocinética aplicada: aminoglicósidos. Revista de la O.F.I.L 1993;3:397-407.
-
(1993)
Revista de la O.F.I.L
, vol.3
, pp. 397-407
-
-
Miranda, M.1
-
36
-
-
0020522160
-
Gentamicin and Tobramycin dosing guidelines. An evaluation
-
Matzke GR, Burkle WS, Lucarotti. Gentamicin and Tobramycin dosing guidelines. An evaluation. Drug Intell Clin Pharm 1983;17:425-32.
-
(1983)
Drug Intell Clin Pharm
, vol.17
, pp. 425-432
-
-
Matzke, G.R.1
Burkle, W.S.2
Lucarotti3
-
37
-
-
0023757326
-
Gentamicin volumes of distribution in patients with hematologic disorders
-
Philips JK, Spearing RL, Crome DJ, Davies JM. Gentamicin volumes of distribution in patients with hematologic disorders. N Engl J Med 1988;10:1290.
-
(1988)
N Engl J Med
, vol.10
, pp. 1290
-
-
Philips, J.K.1
Spearing, R.L.2
Crome, D.J.3
Davies, J.M.4
|